{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:00:06Z","timestamp":1790312406617,"version":"4.1.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nephrol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Despite advances in the understanding and treatment of lupus nephritis (LN), long-term renal and patient outcomes remain suboptimal. Identifying reliable predictors of prognosis and early treatment response is essential for improving risk stratification and guiding management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of patients with biopsy-proven LN. Long-term renal and patient survival, renal response at 6 and 12 months, and predictors of a composite outcome (doubling of serum creatinine, end-stage kidney disease [ESKD], or death) were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 147 patients were included, with a median follow-up of 39.5 months. 10.3% of patients had a doubling of serum creatinine, 11.0% progressed to ESKD, and 6.8% died. Proteinuria &amp;lt;0.7 g\/day was achieved by 49.1% and 54.4% of patients at 6 and 12 months, respectively. In multivariate analysis, baseline predictors of the composite outcome included age &amp;gt;50 years, proteinuria \u22653 g\/day, and hemoglobin &amp;lt;10 g\/dL, while an activity index \u22659 and low baseline C4 levels showed a protective trend. Achieving proteinuria &amp;lt;0.7 g\/day at 12 months emerged as the strongest protective factor. A prognostic score demonstrated good discrimination (area under the curve [AUC] 0.82), which improved further with the addition of proteinuria at 12 months (AUC 0.86).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this biopsy-proven LN cohort, early renal response, particularly proteinuria &amp;lt;0.7 g\/day at 12 months, was the strongest predictor of long-term renal and patient survival. These findings support a dynamic, response-based approach to prognostication in LN and provide the basis for a clinically applicable prognostic score that requires external validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneph.2026.1945616","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:27:41Z","timestamp":1790310461000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of renal and patient survival in lupus nephritis: a 28-year single-center cohort study"],"prefix":"10.3389","volume":"6","author":[{"given":"Alexandra","family":"Vrabie","sequence":"first","affiliation":[{"name":"Nephrology Department, \u201cCarol Davila\u201d University of Medicine and Pharmacy","place":["Bucharest, Romania"]},{"name":"Nephrology Department, Bra\u015fov Emergency Clinical Hospital","place":["Bra\u015fov, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Obri\u015fc\u0103","sequence":"additional","affiliation":[{"name":"Nephrology Department, \u201cCarol Davila\u201d University of Medicine and Pharmacy","place":["Bucharest, Romania"]},{"name":"Nephrology Department, Fundeni Clinical Institute","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Sorohan","sequence":"additional","affiliation":[{"name":"Nephrology Department, \u201cCarol Davila\u201d University of Medicine and Pharmacy","place":["Bucharest, Romania"]},{"name":"Kidney Transplantation Department, Fundeni Clinical Institute","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Jurubi\u0163\u0103","sequence":"additional","affiliation":[{"name":"Nephrology Department, \u201cCarol Davila\u201d University of Medicine and Pharmacy","place":["Bucharest, Romania"]},{"name":"Nephrology Department, Fundeni Clinical Institute","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camelia","family":"Achim","sequence":"additional","affiliation":[{"name":"Nephrology Department, \u201cCarol Davila\u201d University of Medicine and Pharmacy","place":["Bucharest, Romania"]},{"name":"Nephrology Department, Fundeni Clinical Institute","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Silvia","family":"Zili\u015fteanu","sequence":"additional","affiliation":[{"name":"Nephrology Department, \u201cCarol Davila\u201d University of Medicine and Pharmacy","place":["Bucharest, Romania"]},{"name":"Nephrology Department, Fundeni Clinical Institute","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea Gabriela","family":"Andronesi","sequence":"additional","affiliation":[{"name":"Nephrology Department, \u201cCarol Davila\u201d University of Medicine and Pharmacy","place":["Bucharest, Romania"]},{"name":"Nephrology Department, Fundeni Clinical Institute","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Lupu\u015foru","sequence":"additional","affiliation":[{"name":"Nephrology Department, \u201cCarol Davila\u201d University of Medicine and Pharmacy","place":["Bucharest, Romania"]},{"name":"Nephrology Department, Fundeni Clinical Institute","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Emanuela","family":"Rusu","sequence":"additional","affiliation":[{"name":"Nephrology Department, \u201cCarol Davila\u201d University of Medicine and Pharmacy","place":["Bucharest, Romania"]},{"name":"Nephrology Department, Fundeni Clinical Institute","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raluca","family":"Bobeic\u0103","sequence":"additional","affiliation":[{"name":"Nephrology Department, Fundeni Clinical Institute","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Georgia","family":"Micu","sequence":"additional","affiliation":[{"name":"Nephrology Department, Fundeni Clinical Institute","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"B\u0103l\u0103nic\u0103","sequence":"additional","affiliation":[{"name":"Nephrology Department, Fundeni Clinical Institute","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Berechet","sequence":"additional","affiliation":[{"name":"Nephrology Department, Fundeni Clinical Institute","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Mocanu","sequence":"additional","affiliation":[{"name":"Nephrology Department, \u201cCarol Davila\u201d University of Medicine and Pharmacy","place":["Bucharest, Romania"]},{"name":"Nephrology Department, Fundeni Clinical Institute","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015etefan","family":"Lujinschi","sequence":"additional","affiliation":[{"name":"Nephrology Department, \u201cCarol Davila\u201d University of Medicine and Pharmacy","place":["Bucharest, Romania"]},{"name":"Nephrology Department, Fundeni Clinical Institute","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicu","family":"Caceaune","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Fundeni Clinical Institute","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gener","family":"Ismail","sequence":"additional","affiliation":[{"name":"Nephrology Department, \u201cCarol Davila\u201d University of Medicine and Pharmacy","place":["Bucharest, Romania"]},{"name":"Nephrology Department, Fundeni Clinical Institute","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.159","article-title":"What is damaging the kidney in lupus nephritis","volume":"12","author":"Davidson","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2017.85","article-title":"Redefining lupus nephritis: clinical implications of pathophysiologic subtypes","volume":"13","author":"Yu","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212732","article-title":"Changing patterns in clinical\u2013histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis","volume":"77","author":"Moroni","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001180","article-title":"Two-year, randomized, controlled trial of Belimumab in lupus nephritis","volume":"383","author":"Furie","year":"2020","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.09.012","article-title":"The lupus nephritis management renaissance","volume":"101","author":"Mejia-Vilet","year":"2022","journal-title":"Kidney Int"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2410965","article-title":"Efficacy and safety of Obinutuzumab in active lupus nephritis","volume":"392","author":"Furie","year":"2025","journal-title":"N Engl J Med"},{"key":"B7","first-page":"keaf677","article-title":"Predictors and long-term impact of sustained complete renal response in lupus nephritis patients over a median 10-year follow-up","volume-title":"Rheumatology (Oxford)","author":"Michelakis","year":"2026"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/art.39594","article-title":"Risk of end\u2010stage renal disease in patients with lupus nephritis, 1971\u20132015: a systematic review and Bayesian meta\u2010analysis","volume":"68","author":"Tektonidou","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs073","article-title":"Survival analysis and causes of mortality in patients with lupus nephritis","volume":"27","author":"Yap","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/ckj\/sfx063","article-title":"Causes and predictors of mortality in biopsy-proven lupus nephritis: the Sarawak experience","volume":"11","author":"Teh","year":"2018","journal-title":"Clin Kidney J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev311","article-title":"The frequency and outcome of lupus nephritis: results from an international inception cohort study","volume":"55","author":"Hanly","year":"2016","journal-title":"Rheumatology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195759","article-title":"Current insights on biomarkers in lupus nephritis: a systematic review of the literature","volume":"11","author":"Palazzo","year":"2022","journal-title":"J Clin Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/life15101497","article-title":"Biomarkers in lupus nephritis: an evidence-based comprehensive review","volume":"15","author":"Vrabie","year":"2025","journal-title":"Life"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008024","article-title":"Development and validation of a prediction score system in lupus nephritis","volume":"96","author":"Tang","year":"2017","journal-title":"Med (Baltimore)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1177\/0961203318776109","article-title":"Histological predictors of renal outcome in lupus nephritis: the importance of tubulointerstitial lesions and scoring of glomerular lesions","volume":"27","author":"Obri\u015fc\u0103","year":"2018","journal-title":"Lupus"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/09612033211034234","article-title":"The relationship between the modified National Institute of Health activity and chronicity scoring system, and the long-term prognosis for lupus nephritis: a retrospective single-center study","volume":"30","author":"Nakagawa","year":"2021","journal-title":"Lupus"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2025-001649","article-title":"Prediction model for renal outcomes in Latin American Mestizo patients with pure proliferative lupus nephritis","volume":"12","author":"Villalobos Navarro","year":"2025","journal-title":"Lupus Sci Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40001-022-00946-y","article-title":"Searching for a prognostic index in lupus nephritis","volume":"28","author":"Rodr\u00edguez-Almaraz","year":"2023","journal-title":"Eur J Med Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int"},{"key":"B22","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2023.09.002","article-title":"KDIGO 2024 clinical practice guideline for the management of LUPUS NEPHRITIS","volume":"105","author":"Rovin","year":"2024","journal-title":"Kidney Int"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2024.09.017","article-title":"Methods for diagnosing proteinuria\u2014when to use which test and why: a review","volume":"85","author":"Hodel","year":"2025","journal-title":"Am J Kidney Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2015-000123","article-title":"A proteinuria cut-off level of 0.7 g\/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial","volume":"2","author":"Tamirou","year":"2015","journal-title":"Lupus Sci Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/art.39026","article-title":"Predictors of long\u2010term renal outcome in lupus nephritis trials: lessons learned from the Euro\u2010Lupus Nephritis Cohort","volume":"67","author":"Dall\u2019Era","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2024.09.028","article-title":"Long-term kidney outcome of lupus nephritis by renal response status","volume":"9","author":"Yap","year":"2024","journal-title":"Kidney Int Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14030665","article-title":"Prognostic factors of the progression of chronic kidney disease and the development of end-stage renal disease in patients with lupus nephritis: a retrospective cohort study","volume":"14","author":"Perge","year":"2025","journal-title":"J Clin Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11175017","article-title":"Predictors of early response, flares, and long-term adverse renal outcomes in proliferative lupus nephritis: a 100-month median follow-up of an inception cohort","volume":"11","author":"Kapsia","year":"2022","journal-title":"J Clin Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac407","article-title":"Characteristics and outcomes of a Hispanic lupus nephritis cohort from Mexico","volume":"62","author":"Zavala-Miranda","year":"2023","journal-title":"Rheumatology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1007\/s10157-022-02232-x","article-title":"A nationwide analysis of renal and patient outcomes for adults with lupus nephritis in Japan","volume":"26","author":"Ikeuchi","year":"2022","journal-title":"Clin Exp Nephrol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/0961203319890681","article-title":"Initial renal histology and early response predict outcomes of Brazilian lupus nephritis patients","volume":"29","author":"Vajgel","year":"2020","journal-title":"Lupus"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316686700","article-title":"Outcome in biopsy-proven Lupus nephritis: evaluation of biopsies from the Norwegian Kidney Biopsy Registry","volume":"26","author":"Norby","year":"2017","journal-title":"Lupus"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315606985","article-title":"Renal flare prediction and prognosis in lupus nephritis Hispanic patients","volume":"25","author":"Mej\u00eda-Vilet","year":"2016","journal-title":"Lupus"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317716320","article-title":"Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience","volume":"26","author":"Momtaz","year":"2017","journal-title":"Lupus"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1191\/0961203305lu2238oa","article-title":"Factors associated with poor outcomes in patients with lupus nephritis","volume":"14","author":"Contreras","year":"2005","journal-title":"Lupus"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.13","article-title":"Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system","volume":"77","author":"Yu","year":"2010","journal-title":"Kidney Int"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10601016","article-title":"Clinical and histopathologic characteristics associated with renal outcomes in lupus nephritis","volume":"12","author":"Rijnink","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"103686","DOI":"10.1016\/j.ekir.2025.11.011","article-title":"Characterizing the NIH activity and chronicity indices in 2 independent lupus nephritis cohorts","volume":"11","author":"Querin","year":"2026","journal-title":"Kidney Int Rep"},{"key":"B41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ekir.2022.09.012","article-title":"Persistent Isolated C3 Hypocomplementemia as a Strong Predictor of End-Stage Kidney Disease in Lupus Nephritis","volume-title":"Kidney Int Rep","author":"Rossi","year":"2022"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3899\/jrheum.191094","article-title":"Risk of renal failure within 10 or 20 years of systemic lupus erythematosus diagnosis","volume":"48","author":"Petri","year":"2021","journal-title":"J Rheumatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1177\/0961203310371154","article-title":"The complex nature of serum C3 and C4 as biomarkers of lupus renal flare","volume":"19","author":"Birmingham","year":"2010","journal-title":"Lupus"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2024-001264","article-title":"Renal response status to predict long-term renal survival in patients with lupus nephritis: results from the Toronto Lupus Cohort","volume":"11","author":"Urowitz","year":"2024","journal-title":"Lupus Sci Med"}],"container-title":["Frontiers in Nephrology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2026.1945616\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:27:43Z","timestamp":1790310463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2026.1945616\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":44,"alternative-id":["10.3389\/fneph.2026.1945616"],"URL":"https:\/\/doi.org\/10.3389\/fneph.2026.1945616","relation":{},"ISSN":["2813-0626"],"issn-type":[{"value":"2813-0626","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"1945616"}}